TruAlt Bioenergy Q1 FY27 Consolidated Revenue Hits ₹6.27 Billion

BENGALURU, INDIA — TruAlt Bioenergy Limited announced its un-audited consolidated financial results for the first quarter ending June 30, 2026 (Q1 FY27) on July 28, 2026, delivering substantial growth across key operational and financial metrics.

The Bengaluru-headquartered biofuel producer reported a consolidated revenue from operations of ₹6.27 billion (₹627 crore), representing a 106.25% year-on-year increase compared to ₹3.04 billion in Q1 FY26. Consolidated net profit for the quarter surged to ₹571.5 million (₹57.15 crore or ₹57.2 crore), up significantly from ₹47.3 million recorded in the corresponding quarter of the previous fiscal year.

Strong Operational Execution Across Ethanol and Green Gas Segments

The company's performance during the quarter was driven by the integration of grain-based operations across its ethanol facilities. TruAlt expanded its total ethanol manufacturing capacity by 43%, increasing installed capacity from 1,400 KLPD in Q1 FY26 to 2,000 KLPD in Q1 FY27.

Within this footprint, approximately 1,300 KLPD (65% of total capacity) has been transitioned to dual-feed technology, allowing the usage of both sugar derivatives and damaged grains unfit for human consumption. This structural shift enabled near year-round production capabilities, mitigating seasonal sugarcane availability constraints.

Segment-Wise Financial Performance

• Ethanol Vertical: Total revenue reached ₹6.26 billion in Q1 FY27 compared to ₹3.15 billion in Q1 FY26. EBITDA for the segment expanded to ₹1.27 billion, generating an EBITDA margin of 20.70% compared to 11.06% in the prior-year period. Profit before tax for the segment stood at ₹732.6 million.

• Compressed BioGas (CBG) Vertical: The segment generated a total income of ₹113.1 million, while EBITDA stood at ₹62.4 million. Operating expenditure increases in the CBG segment were primarily driven by planned, non-recurring maintenance activities designed to enhance asset reliability.

• Retail Fuel Network: Operations across 7 operational retail outlets yielded a total income of ₹44.0 million and a net profit of ₹0.5 million during the quarter. Four additional outlets are currently under construction under Phase 1 of the company's retail expansion plan.

Official Sources Section

According to official regulatory filings submitted to the BSE Limited and the National Stock Exchange of India Limited on July 28, 2026, the company's Board of Directors approved the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. Further detail on capital allocation, project updates, and operational timelines was disclosed in the official Q1 FY27 investor presentation filed under Regulation 30 of SEBI (LODR) Regulations, 2015.

Quote Section

In an official statement accompanying the results disclosure, Vijay Nirani, Managing Director of TruAlt Bioenergy Limited, stated:

"For TruAlt Bioenergy, Q1 FY27 marks a defining milestone as we report our first year-on-year first quarter performance as a listed company. The successful integration of approximately 1,300 KLPD of dual-feed infrastructure within our total installed capacity of 2,000 KLPD has fundamentally reshaped our business from a seasonal sugarcane-based producer into a near year-round multi-feedstock ethanol producer. Going forward, our focus will be on maximising the potential of this platform by enhancing operational efficiency, optimising asset utilisation, and pursuing high-value downstream opportunities."

Why It Matters

India's push toward energy independence and foreign exchange preservation through the Ethanol Blended Petrol (EBP) program has accelerated demand for indigenous biofuel production. TruAlt Bioenergy's shift toward multi-feedstock operations protects supply stability against crop seasonality while positioning the company to participate in next-generation fuel verticals, including Sustainable Aviation Fuel (SAF) and Compressed BioGas (CBG).

The company is currently developing a proposed 100 million litres per annum Ethanol-to-Jet SAF facility in Srikakulam, Andhra Pradesh, supported by a ₹1.5 billion (₹150 crore) grant sanctioned under the PM JI-VAN Yojana.

Key Facts at a Glance

• Installed Capacity: 2,000 KLPD ethanol capacity, with 1,300 KLPD dual-feed operational capability.

• Capacity Utilisation: Consolidated capacity utilisation stood at 60.57% during Q1 FY27.

• Green Gas Expansion: Development of 4 CBG units underway in partnership with Sumitomo Corporation, with commissioning targeted to begin from Q2 FY27 onwards.

• Strategic JVs: Active partnerships with GAIL (India) Limited via Leafiniti Bioenergy for 6 CBG projects across Karnataka and Maharashtra.

• SAF Roadmap: Project development progressing in Front-End Engineering Design (FEED) phase with Honeywell UOP for the Andhra Pradesh SAF facility.

Frequently Asked Questions (FAQ)

What were TruAlt Bioenergy's key financial figures for Q1 FY27?

TruAlt Bioenergy reported consolidated revenue from operations of ₹6.27 billion (₹627 crore) and a consolidated net profit of ₹571.5 million (₹57.15 crore) for the quarter ended June 30, 2026.

What caused the increase in profit margins in Q1 FY27?

Margin expansion was driven by the integration of grain-based ethanol manufacturing, which yields approximately 6% higher profitability than sugar-based operations, alongside increased operational scale and capacity utilization.

What is the status of TruAlt Bioenergy's Compressed BioGas (CBG) projects?

TruAlt Gas Pvt. Ltd. is constructing 4 CBG plants (Mudhol, Kerakalmatti, Badami, and Bhima Patas) with Sumitomo Corporation, with phased commissioning scheduled from Q2 FY27 onwards. An additional 6 plants are planned with GAIL (India) Limited.

What is TruAlt's progress in Sustainable Aviation Fuel (SAF)?

The company is setting up a 310 KLPD (100 million litres/annum) Ethanol-to-Jet SAF facility at Srikakulam, Andhra Pradesh, using technology licensed from Honeywell UOP.

Source: Official filings with BSE Limited and National Stock Exchange of India Limited; TruAlt Bioenergy Limited Q1 FY27 Investor Presentation.